Pang‐Hsien Tu

6.2k citations

48 papers · 5.0k indexed · 2 hit papers · h-index 33

Neurology top 0.2%
Molecular Biology top 5%
Physiology top 1%
Cellular and Molecular Neuroscience top 1%
Neurology top 1%

Co-authors: John Q. Trojanowski Takeshi Iwatsubo Shigeo Nakajo Kazuyasu Nakaya Masaya Baba Tatsuo Tomita Virginia M.‐Y. Lee Yijuang Chern
Topics: Amyotrophic Lateral Sclerosis Research (13 papers)Alzheimer's disease research and treatments (9 papers)Parkinson's Disease Mechanisms and Treatments (6 papers)
Cited by: Neurology Cellular and Molecular Neuroscience
Journals: Journal of the American Chemical Society Physical Review Letters Nature Communications
Partner nations: Taiwan United States Japan

In The Last Decade

Pang‐Hsien Tu

47 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

1998 1.4k citations Shigeo Nakajo, Pang‐Hsien Tu et al. profile →
Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein

1998 558 citations Pang‐Hsien Tu, James E. Galvin et al. Annals of Neurology profile →

Peers

Countries citing papers authored by Pang‐Hsien Tu

Since Specialization

Citations

This map shows the geographic impact of Pang‐Hsien Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pang‐Hsien Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pang‐Hsien Tu more than expected).

Fields of papers citing papers by Pang‐Hsien Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pang‐Hsien Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pang‐Hsien Tu. The network helps show where Pang‐Hsien Tu may publish in the future.

Co-authorship network of co-authors of Pang‐Hsien Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Pang‐Hsien Tu. A scholar is included among the top collaborators of Pang‐Hsien Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pang‐Hsien Tu. Pang‐Hsien Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice 2017 ·EMBO Molecular Medicine ·(unknown),(unknown),(unknown),Chen Lin,(unknown),(unknown),Chi‐Wei Chang,Ren‐Shyan Liu,Rita P.‐Y. Chen,Pang‐Hsien Tu	52
2	Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism 2014 ·Autophagy ·(unknown),(unknown),Guang‐Chao Chen,Yijuang Chern,Pang‐Hsien Tu	136
3	USP11 regulates PML stability to control Notch-induced malignancy in brain tumours 2014 ·Nature Communications ·(unknown),Yu‐Ching Lin,Cheng‐Hsin Liu,(unknown),Yating Wang,Ya‐Wen Lin,Hsin‐I Ma,Pang‐Hsien Tu,Sean Lawler,Ruey‐Hwa Chen	87
4	A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease 2013 ·Human Molecular Genetics ·Han‐Yun Hsiao,Yu‐Chen Chen,Huimei Chen,Pang‐Hsien Tu,Yijuang Chern	175
5	Exome Sequencing Identifies GNB4 Mutations as a Cause of Dominant Intermediate Charcot-Marie-Tooth Disease 2013 ·The American Journal of Human Genetics ·Bing‐Wen Soong,Yen‐Hua Huang,Pei‐Chien Tsai,Chien‐Chang Huang,Hung-Chuan Pan,(unknown),(unknown),Tze-Tze Liu,(unknown),Kon-Ping Lin,Pang‐Hsien Tu,Lung‐Sen Kao,Yi‐Chung Lee	37
6	Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma 2013 ·Hepatology ·(unknown),Kuen‐Tyng Lin,Shu‐Chuan Chen,De-Leung Gu,Chian‐Feng Chen,Pang‐Hsien Tu,Yuh‐Shan Jou	42
7	A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan 2012 ·Neurobiology of Aging ·(unknown),Bing‐Wen Soong,Pang‐Hsien Tu,Kon‐Ping Lin,Jong‐Ling Fuh,Pei‐Chien Tsai,Yi‐Chun Lu,I‐Hui Lee,Yi‐Chung Lee	45
8	Predisposing factors of pituitary hemorrhage 2011 ·European Journal of Neurology ·Zhuo‐Hao Liu,Pang‐Hsien Tu,(unknown),Nan-Yu Chen,(unknown),Chi‐Cheng Chuang	13
9	Hyperphosphorylation as a Defense Mechanism to Reduce TDP-43 Aggregation 2011 ·PLoS ONE ·(unknown),(unknown),(unknown),(unknown),Pang‐Hsien Tu	94
10	Identification of Oncogenic Point Mutations and Hyperphosphorylation of Anaplastic Lymphoma Kinase in Lung Cancer 2011 ·Neoplasia ·Yiwei Wang,Pang‐Hsien Tu,Kuen‐Tyng Lin,Shuchen Lin,Jenq‐Yuh Ko,Yuh‐Shan Jou	39
11	Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response 2011 ·Radiation Oncology ·Pei-Ming Chu,Shih‐Hwa Chiou,Tsann-Long Su,Yi‐Jang Lee,Li-Hsin Chen,Yi‐Wei Chen,Sang-Hue Yen,Ming-Teh Chen,Ming‐Hsiung Chen,Yang‐Hsin Shih,Pang‐Hsien Tu,Hsin-I Ma	20
12	FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS 2010 ·Neurobiology of Aging ·(unknown),Bing‐Wen Soong,Kon‐Ping Lin,Pang‐Hsien Tu,(unknown),Yi‐Chung Lee	59
13	Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway 2010 ·Biochemical Pharmacology ·Li-Hsin Chen,Che-Chuan Loong,Tsann-Long Su,Yi‐Jang Lee,Pei-Ming Chu,Ming‐Long Tsai,(unknown),Pang‐Hsien Tu,Chin‐Wen Chi,Hsin‐Chen Lee,Shih-Hwa Chiou	44
14	Induction of Amyloid Fibrils by the C-Terminal Fragments of TDP-43 in Amyotrophic Lateral Sclerosis 2010 ·Journal of the American Chemical Society ·Kuei‐Ho Chen,Ryan Yeh‐Yung Lin,(unknown),Pang‐Hsien Tu,Rita P.‐Y. Chen,(unknown),Wenlung Chen,Chih‐Hsien Wang,Joseph Jen‐Tse Huang	120
15	Cytophagic histiocytic panniculitis with fatal haemophagocytic lymphohistiocytosis in a paediatric patient with perforin gene mutation 2007 ·Journal of Clinical Pathology ·Rong‐Long Chen,(unknown),Ikuyo Ueda,Shinsaku Imashuku,Kengo Takeuchi,Pang‐Hsien Tu,Shih‐Sung Chuang	13
16	Metachronous secondary atypical meningioma and anaplastic astrocytoma after postoperative craniospinal irradiation for medulloblastoma 2006 ·Child s Nervous System ·Andrew Hope,David B. Mansur,Pang‐Hsien Tu,Joseph R. Simpson	21
17	Novel Ubiquitin Neuropathology in Frontotemporal Dementia WithValosin-Containing ProteinGene Mutations 2006 ·Journal of Neuropathology & Experimental Neurology ·Mark S. Forman,Ian R. Mackenzie,Nigel J. Cairns,Eric A. Swanson,Philip J. Boyer,David A. Drachman,(unknown),Jason Karlawish,Alan Pestronk,Thomas W. Smith,Pang‐Hsien Tu,Giles D. Watts,William R. Markesbery,Charles D. Smith,Virginia Kimonis	173
18	Incidental pediatric intraparenchymal xanthogranuloma 2005 ·Journal of Neurosurgery Pediatrics ·William W. Ashley,Prithvi Narayan,Tae Sung Park,Pang‐Hsien Tu,Arie Perry,Jeffrey R. Leonard	19
19	Symptomatic Intraosseous Synovial Cyst in the Cervical Spine: A Case Report 2003 ·Spine ·Sarah C. Jost,Pang‐Hsien Tu,Neill M. Wright	27
20	Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synucleinbreakdown → 1998 ·Annals of Neurology ·Pang‐Hsien Tu,James E. Galvin,Minami Baba,Benoit I. Giasson,Taisuke Tomita,Susan Leight,Shigeo Nakajo,Takeshi Iwatsubo,John Q. Trojanowski,Virginia M.‐Y. Lee	558

About Pang‐Hsien Tu

Pang‐Hsien Tu is a scholar working on Neurology, Genetics and Cellular and Molecular Neuroscience, having authored 48 papers that have together received 5.0k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (13 papers), Alzheimer's disease research and treatments (9 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). The work is most often cited by research in Neurology (3.1k citations), Neurology (847 citations) and Cellular and Molecular Neuroscience (1.3k citations). Pang‐Hsien Tu has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include John Q. Trojanowski, Takeshi Iwatsubo, Shigeo Nakajo, Kazuyasu Nakaya, Masaya Baba, Tatsuo Tomita, Virginia M.‐Y. Lee, Yijuang Chern, Taisuke Tomita and Susan Leight. Their work appears in journals such as Journal of the American Chemical Society, Physical Review Letters and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact